DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release: * * * Ablation reduces stroke risk for AFib and may remove need for some types of blood thinners * Research Highlights: * Successful catheter ablation resulted in a low risk of stroke associated with atrial fibrillation (AFib), a type of irregular heart rhythm, according to an international study. * Researchers said these findings may suggest that ongoing blood-thinning me  more

CLEVELAND, Ohio, Nov. 8 [Category: BizHospital] -- The Cleveland Clinic posted the following news release: * * * Cleveland Clinic First-In-Human Trial of CRISPR Gene-Editing Therapy Shown to Safely Lower Cholesterol and Triglycerides * Results from a Cleveland Clinic Phase 1, first-in-human clinical trial showed that a one-time infusion of a gene-editing therapy using CRISPR-Cas9 safely reduced LDL ("bad") cholesterol and triglycerides in people with lipid disorders resistant to current medi  more

DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release: * * * First-in-human trial of CRISPR gene-editing therapy safely lowered cholesterol, triglycerides * Research Highlights: * In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and reduced triglycerides by about 55%. * Cholesterol  more

BOSTON, Massachusetts, Nov. 8 [Category: BizHospital] -- Mass General Brigham issued the following news release: * * * Mass General Brigham Researchers Find PCSK9 Inhibitor Reduced Risk of First Heart Attack, Stroke * In a clinical trial of 12,257 patients at high risk, investigators found that adding the drug evolocumab to a patient's treatment reduced the risk of a first heart attack, first stroke, or coronary heart disease death by 25%. Researchers from Mass General Brigham have unveile  more

DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release: * * * PCSK9 inhibitor reduced major CVD events in adults with no prior heart attack or stroke * Research Highlights: * Results from the international VESALIUS-CV (TIMI 66) clinical trial found that among adults with atherosclerotic cardiovascular disease (ASCVD) or diabetes and no history of a prior heart attack or stroke, the PCSK9 inhibitor evolocumab reduced the risk of co  more

LONDON, England, Nov. 9 -- The National Institute for Health and Care Research issued the following news: * * * Radiotherapy after mastectomy can be avoided Women with early-stage breast cancer can avoid radiotherapy after mastectomy as it does not affect long-term survival, new research finds. An international trial found that patients with early-stage breast cancer who underwent a mastectomy (breast removal) and were taking anti-cancer drugs had similar 10-year survival rates, whether or n  more

WASHINGTON, Nov. 7 -- Sen. Edward J. Markey, D-Massachusetts, issued the following news release: * * * Senator Markey, Entire Massachusetts Delegation Demand Trump Administration Halt Firing of National Park Staff Trump plans to eliminate 60+ positions in NPS Northeast Regional Office  * Senator Edward J. Markey (D-Mass.), a member of the Environment and Public Works Committee, today led the full Massachusetts delegation Senator Elizabeth Warren (D-Mass.) and Representatives Richard Neal (  more

BOSTON, Massachusetts, Nov. 8 [Category: BizHospital] -- Mass General Brigham issued the following news release: * * * Triglyceride-Lowering Drug Significantly Reduced Rate of Acute Pancreatitis in High-Risk Patients * In two placebo-controlled clinical trials, researchers at Mass General Brigham found that olezarsen benefited those with severe hypertriglyceridemia. Researchers from Mass General Brigham have found that olezarsena drug designed to lower triglyceride levelscan also decrease   more